B
ANGO icon

Bailard’s AngioDynamics ANGO Stock Holding History

Bailard’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,700
Closed -$241K – 759
2025
Q1 		$241K Buy
+25,700
New +$270K 0.01% 641
2022
Q1 		– Sell
-9,600
Closed -$265K – 722
2021
Q4 		$265K Buy
+9,600
New +$265K 0.01% 574
2018
Q3 		– Sell
-16,100
Closed -$358K – 529
2018
Q2 		$358K Hold
16,100
– – 0.02% 426
2018
Q1 		$278K Buy
+16,100
New +$269K 0.02% 422

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bailard's ANGO Position: Q2 2025 in Review

Bailard sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 25,700 shares — an estimated $241K sold.

Bailard first reported a position in ANGO in Q1 2018 and held it in 4 quarters. The position peaked at $358K in Q2 2018. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.

  • Bailard reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
  • Bailard sold 25,700 AngioDynamics shares in Q2 2025, an estimated $241K.
  • Bailard first reported a position in AngioDynamics in Q1 2018 and held it in 4 quarters.
  • Bailard's AngioDynamics position peaked at $358K in Q2 2018.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.

Based on Bailard's 13F filing for Q2 2025, filed 8 Aug 2025.